B
Beam Therapeutics Inc.
BEAM · NASDAQ · Healthcare · 2.8B
Closing price
$25.70
+4.47% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.1×
Enterprise value / EBITDAEV/EBITDA
-181.9×
Free cash flow yieldFCF yield
-14.2%
Return on equityROE
-6.5%
Operating margin
-274.6%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
-8.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.